Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myelosuppression-Adult”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Post-approval studies (Phase 4)UnknownNCT03793205
What this trial is testing

G-CSF for the Prevention of Febrile Neutropenia in Gynecologic Cancer Patients

Who this might be right for
Gynecologic CancerMyelosuppression AdultFebrile Neutropenia+1 more
Lei Li 100
Early research (Phase 1)Study completedNCT00005796
What this trial is testing

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

Who this might be right for
Bone Marrow SuppressionBrain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/Organ
Indiana University 10
Large-scale testing (Phase 3)UnknownNCT03740464
What this trial is testing

Long-acting G-CSF for Febrile Neutropenia

Who this might be right for
Epithelial Ovarian CancerColony Stimulating FactorsFebrile Neutropenia+3 more
Lei Li 556
Post-approval studies (Phase 4)Not Yet RecruitingNCT06665737
What this trial is testing

Outcomes of Early and Late Administration G-CSF for Primary Prophylaxis in Non-Hodgkin's Lymphoma Patients

Who this might be right for
Non-Hodgkin's Lymphoma (NHL)Granulocyte Colony Stimulating FactorFebrile Neutropenia (FN)+1 more
Department of Medical Services Ministry of Public Health of Thailand 126
Not applicableUnknownNCT01193933
What this trial is testing

Multicenter Clinical Trial for Adult Ph-negative ALL. Non-intensive But Non-iterruptive Treatment

Who this might be right for
Ph-negative Adult Acute Lymphoblastic Leukemia
National Research Center for Hematology, Russia 321
Not applicableStudy completedNCT03098589
What this trial is testing

Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)

Who this might be right for
Lymphoma
Celgene 1,149
Testing effectiveness (Phase 2)Ended earlyNCT04887831
What this trial is testing

Trilaciclib, a CDK 4/6 Inhibitor, in Patients With Advanced/Metastatic Bladder Cancer Receiving Chemotherapy Then Avelumab

Who this might be right for
Urothelial CarcinomaBladder CancerMyelosuppression Adult+2 more
G1 Therapeutics, Inc. 92
Not applicableApproved For MarketingNCT04504513
What this trial is testing

Expanded Access to Trilaciclib for Patients Receiving Chemotherapy for Small Cell Lung Cancer

Who this might be right for
Myelosuppression AdultChemotherapeutic ToxicitySmall Cell Lung Cancer
G1 Therapeutics, Inc.
Early research (Phase 1)Study completedNCT00020371
What this trial is testing

BMS-247550 in Treating Patients With Cancers That Have Not Responded to Previous Therapy

Who this might be right for
Unspecified Adult Solid Tumor, Protocol SpecificNeutropenia
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Ended earlyNCT04607668
What this trial is testing

Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer (mCRC):

Who this might be right for
Colorectal Cancer MetastaticMyelosuppression-AdultChemotherapeutic Toxicity
G1 Therapeutics, Inc. 326
Large-scale testing (Phase 3)Study completedNCT00003805
What this trial is testing

Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count

Who this might be right for
Bone Marrow SuppressionFever, Sweats, and Hot FlashesInfection+6 more
European Organisation for Research and Treatment of Cancer - EORTC 859